Viking Therapeutics' stock soars after positive obesity treatment results

VK2735, a GLP-1/GIP treatment by Viking Therapeutics, maintains weight loss in clinical trials.

Published 7sem2 sources✓ ConfirmedNotableupdated 7sem

≈ 15sSpeed

The fact

The company's stock surged following the results announcement.

The treatment could compete with Eli Lilly's Zepbound.

2 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 2 media sources · identified on September 22, 2026